MedPath

PDI-320

Generic Name
PDI-320

An Evaluation of PDI-320 in Comparison to Its Monads in Adults With Rosacea

Phase 2
Conditions
Rosacea
Interventions
Drug: PDI-320 Monad #1
Drug: PDI-320 Monad #2
Drug: Vehicle
First Posted Date
2013-04-10
Last Posted Date
2014-05-29
Lead Sponsor
PreCision Dermatology, Inc.
Target Recruit Count
200
Registration Number
NCT01828177
Locations
🇺🇸

Academic Dermatology Associates, Albuquerque, New Mexico, United States

🇺🇸

Therapeutics Clinical Research, San Diego, California, United States

© Copyright 2025. All Rights Reserved by MedPath